You are Here : Aurobindo under CBI scanner: Is it still a buy?

Tuesday, 10:52

Surajit Pal, pharma analyst at Elara Capital feels that investors can enter the stock around Rs 100 given its fundamentals. I believe the current price roughly around Rs 100 will be the right price to enter considering the prospect in the company for this year and next year in immediate terms, he told CNBC-TV18.
MAR 29, 2017
04:55 PM

cnbc tv18 shows

All Shows


Markets Today

What's happened in the markets through the day? What are top experts & brokerages betting on? What's happening in the global economy? What about market moving business stories? Which government policies will impact the markets? For all this & more, watch Markets Today - a show that g ... more »

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Follow us on
Available On